Topics: Chronic diseases

Dr Keshav Raj Paudel, an early career researcher at the Centenary UTS Centre for Inflammation has been awarded the prestigious ÔThoracic Society of Australia and New Zealand (TSANZ) Maurice Blackburn Grant-In-Aid for Occupational Lung DiseaseÕ for 2021.

Researchers from the Centenary UTS Centre for Inflammation and collaborators have been awarded a seed grant of $20,000 to advance a new treatment strategy for chronic obstructive pulmonary disease (COPD) patients suffering from influenza.

Professor Philip Hogg, Head, ACRF Centenary Cancer Research Centre, has featured on Nine News explaining his new theranostics research, recently funded by the Cancer Institute NSW. A form of personalised cancer treatment for the patient, the term ‘theranostics’ refers to a combined therapy and diagnostics approach where tumour markers are employed to deliver a therapeutic isotope ...

Hi, I’m Professor Hersey and I am the Head of the Melanoma Oncology and Immunology Program at Centenary.

Researchers at the Centenary Institute and the University of Technology Sydney have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease (COPD), an inflammatory lung disease that causes airway blockage and that makes it difficult to breathe.

A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.